1. Home
  2. INVE vs CLSD Comparison

INVE vs CLSD Comparison

Compare INVE & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • CLSD
  • Stock Information
  • Founded
  • INVE 1990
  • CLSD 2011
  • Country
  • INVE United States
  • CLSD United States
  • Employees
  • INVE N/A
  • CLSD N/A
  • Industry
  • INVE Computer peripheral equipment
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • CLSD Health Care
  • Exchange
  • INVE Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • INVE 93.6M
  • CLSD 76.6M
  • IPO Year
  • INVE 1997
  • CLSD 2016
  • Fundamental
  • Price
  • INVE $3.89
  • CLSD $1.01
  • Analyst Decision
  • INVE Strong Buy
  • CLSD Strong Buy
  • Analyst Count
  • INVE 2
  • CLSD 6
  • Target Price
  • INVE $7.25
  • CLSD $5.33
  • AVG Volume (30 Days)
  • INVE 103.4K
  • CLSD 230.0K
  • Earning Date
  • INVE 11-07-2024
  • CLSD 11-12-2024
  • Dividend Yield
  • INVE N/A
  • CLSD N/A
  • EPS Growth
  • INVE N/A
  • CLSD N/A
  • EPS
  • INVE 3.10
  • CLSD N/A
  • Revenue
  • INVE $104,217,000.00
  • CLSD $7,703,000.00
  • Revenue This Year
  • INVE N/A
  • CLSD N/A
  • Revenue Next Year
  • INVE N/A
  • CLSD $91.87
  • P/E Ratio
  • INVE $1.27
  • CLSD N/A
  • Revenue Growth
  • INVE 70.57
  • CLSD 248.39
  • 52 Week Low
  • INVE $2.95
  • CLSD $0.92
  • 52 Week High
  • INVE $9.24
  • CLSD $2.12
  • Technical
  • Relative Strength Index (RSI)
  • INVE 50.54
  • CLSD 42.14
  • Support Level
  • INVE $3.89
  • CLSD $0.99
  • Resistance Level
  • INVE $4.25
  • CLSD $1.05
  • Average True Range (ATR)
  • INVE 0.20
  • CLSD 0.05
  • MACD
  • INVE -0.02
  • CLSD 0.00
  • Stochastic Oscillator
  • INVE 28.89
  • CLSD 15.38

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: